CRON
CRON
NASDAQ · Pharmaceuticals

Cronos Group Inc

$2.83
-0.06 (-2.08%)
As of Aug 8, 1:41 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +955.8% upside
Low Target $20.40
Average Target $29.88
High Target $34.19
Current Price $2.83
Current
$2.83
Target
$29.88
$20.40 $29.88 avg $34.19
Scenario Analysis
Bear Case
$20.40
620.8%
Low target
Base Case
$29.88
+955.8%
Avg target
Bull Case
$34.19
+1,108.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.66
-39.3% from high
52-Week Low
$2.81
+0.7% from low
Target vs 52W High
$29.88
+541.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%